Effect heterogeneity by trust and family orientation. by Fabrice Etilé (4741332)

Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

Fitted estimates and significance levels of linear mixed models for seedling germination, survival and growth. by Laura García de Jalón (8939456)

Summary of significant intervals for each effect. by Qian Hu (205735)

“…In general, this study provides theoretical basis and empirical experience for how to enhance government trust and ultimately promote the construction of national governance system, given the increasing influence of unofficial media. …”

Differences in COVID-19 vaccine trust and hesitancy. by Hocheol Lee (3958376)

Subjects:

Join-point regression analysis of the statistically significant linear increase in use of antidementia and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

Linear regression. by Myriam Aïche (22290591)

Analyzed path model omitting most non-significant paths to reduce visual clutter. by Matthew S. VanDyke (14797310)

Risk-adjusted outcomes for mental health trusts. by Paris Pariza (21237935)

Subjects:

Risk-adjusted outcomes for acute hospital trusts. by Paris Pariza (21237935)

Subjects:

Statistically significant linear increase in use of psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics, gabapentinoids during the observed time period. by Jelena Filimonovic (22305307)

Drug company payments to NHS foundation trusts and non-foundation NHS trusts, 2015–2018. by Piotr Ozieranski (7640876)

Subjects:

Linear contact model. by Qingwen Li (1510687)

Descriptive statistics for the trust in healthcare system scale. by Željko Pavić (12174363)

Model estimates and significance levels from linear mixed-effect models of ECM root tip colonization. by Laura García de Jalón (8939456)

Join-point regression analysis of the statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period. by Jelena Filimonovic (22305307)

Phase 2 significant effects. by Wendy C. Crone (2262169)

Phase 1 significant effects. by Wendy C. Crone (2262169)

Linear correlations between vitamin D and study parameters. by Saleh Nazmy Mwafy (14886192)

Histogram of cladogram and linear discriminant analysis (LDA) score. by Nguyen Thi Hai (12700147)